Zhu Chaoyang, Xu Liang, Chen Longxin, Zhang Zihan, Zhang Yuhan, Wu Weiping, Li Chengxiang, Liu Shuang, Xiang Shuqin, Dai Shengwang, Zhang Jay, Guo Hui, Zhou Yinjian, Wang Feng
Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100101, China.
ACS Cent Sci. 2023 Jun 6;9(6):1229-1240. doi: 10.1021/acscentsci.3c00265. eCollection 2023 Jun 28.
No current methods can selectively elicit an antibody response to a specific conformational epitope in a whole antigen in vivo. Here, we incorporated ε-acryloyl-l-lysine (AcrK) or ε-crotonyl-l-lysine (Kcr) with cross-linking activities into the specific epitopes of antigens and immunized mice to generate antibodies that can covalently cross-link with the antigens. By taking advantage of antibody clonal selection and evolution in vivo, an orthogonal antibody-antigen cross-linking reaction can be generated. With this mechanism, we developed a new approach for facile elicitation of antibodies binding to specific epitopes of the antigen in vivo. Antibody responses were directed and enriched to the target epitopes on protein antigens or peptide-KLH conjugates after mouse immunization with the AcrK or Kcr-incorporated immunogens. The effect is so prominent that the majority of selected hits bind to the target epitope. Furthermore, the epitope-specific antibodies effectively block IL-1β from activating its receptor, indicating its potential for the development of protein subunit vaccines.
目前尚无方法能够在体内选择性地引发针对全抗原中特定构象表位的抗体反应。在此,我们将具有交联活性的ε-丙烯酰基-L-赖氨酸(AcrK)或ε-巴豆酰基-L-赖氨酸(Kcr)引入抗原的特定表位,并免疫小鼠以产生能够与抗原共价交联的抗体。通过利用体内抗体的克隆选择和进化,可以产生一种正交的抗体-抗原交联反应。基于此机制,我们开发了一种在体内轻松引发结合抗原特定表位抗体的新方法。在用掺入AcrK或Kcr的免疫原免疫小鼠后,抗体反应被导向并富集到蛋白质抗原或肽-KLH缀合物上的目标表位。效果非常显著,以至于大多数筛选出的抗体都能结合目标表位。此外,表位特异性抗体能有效阻断IL-1β激活其受体,表明其在蛋白质亚单位疫苗开发方面的潜力。